Genetically engineered membrane-based nanoengagers for immunotherapy of pancreatic cancer

Genetically engineered membrane-based nanoengagers for immunotherapy of pancreatic cancer

Abstract Modulating macrophages presents a promising avenue in tumor immunotherapy. However, tumor cells have evolved mechanisms to evade macrophage activation and phagocytosis. Herein, we introduced a bispecific antibody-based nanoengager to facilitate the recognition and phagocytosis of tumor cell...

Full description

Bibliographic Details
Main Authors: Haoqi Zhang, Yuanke Li, Helong Kang, Jingping Lan, Lin Hou, Zhengbang Chen, Fan Li, Yanqin Liu, Jiliang Zhao, Na Li, Yajuan Wan, Yiping Zhu, Zhen Zhao, Hongkai Zhang, Jie Zhuang, Xinglu Huang
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Journal of Nanobiotechnology
Subjects:
Nanoengagers
Macrophages
Cell membrane
Pancreatic cancer
Online Access:https://doi.org/10.1186/s12951-024-02369-9

Internet

https://doi.org/10.1186/s12951-024-02369-9

Similar Items